Ameriprise’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Ameriprise’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,086	Closed	-$657K	–	4061
2023 Q1	$657K	Sell	45,086 -192,522	-81%	-$2.72M	﹤0.01%	3323
2022 Q4	$1.73M	Hold	237,608	–	–	﹤0.01%	2869
2022 Q3	$1.64M	Hold	237,608	–	–	﹤0.01%	2865
2022 Q2	$1.66M	Hold	237,608	–	–	﹤0.01%	2885
2022 Q1	$1.96M	Hold	237,608	–	–	﹤0.01%	2922
2021 Q4	$2.57M	Sell	237,608 -35,000	-13%	-$378K	﹤0.01%	2850
2021 Q3	$3.3M	Hold	272,608	–	–	﹤0.01%	2643
2021 Q2	$3.31M	Hold	272,608	–	–	﹤0.01%	2696
2021 Q1	$3.8M	Hold	272,608	–	–	﹤0.01%	2557
2020 Q4	$3.86M	Sell	272,608 -444,287	-62%	-$5.8M	﹤0.01%	2437
2020 Q3	$8.82M	Buy	+716,895	New	+$8.3M	﹤0.01%	1643

Ameriprise's AMYT Position: Q2 2023 in Review

Ameriprise sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 45,086 shares — an estimated $657K sold.

Ameriprise first reported a position in AMYT in Q3 2020 and held it in 11 quarters. The position peaked at $8.82M in Q3 2020. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Ameriprise reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Ameriprise sold 45,086 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $657K.
Ameriprise first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 11 quarters.
Ameriprise's Amryt Pharma plc American Depositary Shares position peaked at $8.82M in Q3 2020.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Ameriprise's 13F filing for Q2 2023, filed 14 Aug 2023.